Screener
PJP vs PBE
Invesco Pharmaceuticals ETF vs Invesco Biotechnology & Genome ETF
Key differences
- Over the last 3 years, PJP has delivered higher annualized returns.
Side-by-side comparison
| PJP | PBE | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.58% |
| Fund size (AUM) | $334M | $247M |
| Since | 2005 | 2005 |
| Dividend yield | 1.01% | 1.09% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +38.9% | +34.1% |
| CAGR 3Y | +14.0% | +10.3% |
| CAGR 5Y | +7.4% | +3.3% |
| Sharpe 3Y | 0.69 | 0.41 |
| Volatility 1Y | 16.19% | 18.63% |
| Max drawdown | -33.95% | -37.84% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and PBE
Explore further